Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia. Leitner DF, Kanshin E, Askenazi M, Siu Y, et al. PLoS One 2022;17:e0268597.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leitner DF, Kanshin E, Askenazi M, Siu Y, et al. Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia. PLoS One 2022;17:e0268597.
PMID: 35587487